Evidence map›Paper›PMID 39775036›Full record

ArticlePloS one2024

Temporal trends in mental health terminology in Alzheimer's disease clinical trials.

Amir-Ali Golrokhian-Sani, Maya Morcos, Alecco Philippi, Reem Al-Rawi, Marc Morcos, Rui Fu

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amir-Ali Golrokhian-SaniFaculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.ORCID 0000-0003-0384-8472
Maya MorcosFaculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.ORCID 0009-0000-1561-6746
Alecco PhilippiFaculty of Health Sciences, Queen's University, Kingston, Ontario, Canada.ORCID 0009-0000-1208-7842
Reem Al-RawiFaculty of Health Sciences, Queen's University, Kingston, Ontario, Canada.
Marc MorcosFaculty of Applied Science and Engineering, University of Toronto, Toronto, Ontario, Canada.ORCID 0009-0005-3744-9930
Rui FuDepartment of Otolaryngology-Head & Neck Surgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite several studies having correlated Alzheimer's disease with mental health conditions, the extent to which they have been incorporated into Alzheimer's disease clinical trials remains unclear.

objectiveThis study aimed to assess the temporal trends in mental health-related terminology in Alzheimer's disease clinical trials as a proxy measure of research interest. Additionally, it sought to determine the effect of the COVID-19 pandemic on the frequency of these terms through pre-pandemic and post-pandemic trend assessment.

methodsIn this retrospective descriptive analysis, we included 2243 trials with a start date between 1988 and 2022 by searching for the keyword "Alzheimer Disease" in the U.S. National Library of Medicine ClinicaTrials.gov database. A Python program was created to extract and count the frequency of four mental health terms (loneliness, depression, anxiety, and distress) by year and trial status (e.g., completed, active, recruiting). Binary logistic regression analyses were conducted to examine the yearly patterns in the appearance of the four mental health terms. A multivariable logistic regression analysis was performed to identify trial characteristics associated with each mental health term.

resultsOur results depicted a statistically significant increasing trend in three (i.e., loneliness, anxiety, distress) of the four mental health conditions by year. A comparison between pre-pandemic and post-pandemic trials showed an increase in the mention of the same three words over time.

interpretationThese results may suggest a growing awareness of mental health conditions and a greater interest in considering these conditions in Alzheimer's disease trials, particularly after the onset of COVID-19. Future researchers should conduct more in-depth analyses to examine how mental health variables are operationalized in these trials, with consideration for their subsequent success.

Indexed as

Alzheimer DiseaseClinical Trials as TopicCOVID-19Mental HealthTerminology as TopicHumansPandemicsRetrospective StudiesSARS-CoV-2United States

Identifiers

PMID39775036
PMCPMC11684645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.